Dr Jason Butler, Senior Haematologist, RBWH

Dr Jason Butler is a Clinical Haematologist with a Senior Staff Specialist appointment at the Royal Brisbane and Women’s Hospital, Nambour General Hospital, and as a Visiting Medical Officer at Icon Cancer Care.

He completed his dual training in Clinical and Laboratory Haematology in 2004 following a research posting at the Queensland Institute of Medical Research investigating the role of bcl-2 in primary resistance in chronic myeloid leukaemia. Following a fellowship year at the Bone Marrow Transplant Unit, Royal Brisbane and Women’s Hospital, he has since been a Staff Specialist with that unit. In addition, he has provided outreach clinic support to the Nambour General Hospital, and has a small private practice with Icon Cancer Care. Dr Butler also completed a Masters in Medical Science (Clinical Epidemiology), to assist with design and development of investigator-initiator research studies.

His major clinical interests are all aspects of malignant haematology, particularly in leukaemia, lymphoma, and myeloma, as well as autologous and allogeneic stem cell transplantation. Other roles include extensive educational support and clinical presentations for patients and health professionals, and advocacy roles as a board member for Lymphoma Australia.

• Presentation unavailable

Dr Cameron Curley, Senior Haematologist, RBWH

Cameron is a Clinical Haematologist and Staff Specialist in the Department of Haematology and Bone Marrow Transplantation at the Royal Brisbane and Women’s Hospital. He graduated from the University of Queensland in 1999 and completed training in Haematology at the Royal Brisbane and Princess Alexandra Hospitals in 2010 before taking up an appointment as a Clinical Haematologist at the RBWH. He provides outreach Haematology Services to Rockhampton and is a visiting medical officer at the Mater Private Hospital, Brisbane and Springfield. He has experience in managing all aspects of haematological malignancy with specific interests in the areas of acute leukaemia and allogeneic stem cell transplantation. He is a member of the National Immunoglobulin Governance Advisory Committee (NIGAC) and the chair of the Specialist Working Group for Haematology, providing guidance in the optimal use of Immunoglobulin therapy.

• Presentation unavailable

Dr Kirk Morris Haematologist, RBWH

Kirk is Acting Director of Clinical Haematology and Bone Marrow Transplantation at Royal Brisbane and Women’s Hospital.  He graduated from the University of Queensland in 1996 and completed haematology training at the Royal Brisbane and Princess Alexandra Hospitals in 2006.  He has a broad experience in all aspects of haemato-oncology with specific interest in novel targeted therapies, the management of adolescent and young adult patients with haematologic malignancies, provision of clinical outreach services to regional Queensland, and the development of computer systems to assist the daily practice of busy clinicians.  He is the primary education supervisor for haematology trainees at the RBWH.

• Presentation unavailable

Dr Zarnie Lwin

Associate Professor Lwin obtained her MBBS from Myanmar, FCP from South Africa, FRACP from Australia, then completed a two-year research fellowship in Toronto, Canada. She is Chair of Co-operative Group of Neurooncology (COGNO) Outreach and Education Committee, including the Outreach Educational Preceptorship Program for Asia-Pacific, and the RBWH Observership. She is Deputy Chair of COGNO International Clinical Research Subcommittee, and Editorial Board Member for the World Federation of Neurooncology Societies Magazine. She has been past Vice-Chair and Treasurer of the Medical Oncology Group of Australia.  She has a strong interest in societal research and neurooncology,and has been invited faculty speaker at national and international scientific meetings. She has been the convenor or scientific committee member for national and international conferences.

• Presentation unavailable

Dr Michelle Nottage, MBChB, FRACP, MMedSci

Dr Nottage is a graduate of Otago University and completed specialist training in Medical Oncology in Brisbane in 2000. 

She undertook a fellowship in Medical Oncology and new drug development at the Princess Margaret Hospital in Toronto before returning to a staff specialist position at the RBWH in 2003.

Dr Nottage’s special interests are  Breast Cancer and Head and Neck Cancers.

• Presentation unavailable

Dr Melissa Eastgate, Dep. Director – Medical Oncology, RBWH

Kirk is Acting Director of Clinical Haematology and Bone Marrow Transplantation at Royal Brisbane and Women’s Hospital.  He graduated from the University of Queensland in 1996 and completed haematology training at the Royal Brisbane and Princess Alexandra Hospitals in 2006.  He has a broad experience in all aspects of haemato-oncology with specific interest in novel targeted therapies, the management of adolescent and young adult patients with haematologic malignancies, provision of clinical outreach services to regional Queensland, and the development of computer systems to assist the daily practice of busy clinicians.  He is the primary education supervisor for haematology trainees at the RBWH.

• Presentation unavailable

Professor Jane Turner Professor of Psychiatry, University of Queensland

Jane Turner is has worked for 25 years as a consultation-liaison psychiatrist in oncology at Royal Brisbane and Women’s Hospital. She has been extensively involved in the development and implementation of clinical practice guidelines, and communication skills training. Her research and clinical interests focus on the emotional impact of advanced cancer, especially on families, and the development of innovative models of psychosocial care in oncology. She is currently leading a trial of a nurse-delivered survivorship intervention for patients who have completed treatment for head and neck cancer, and is investigator in a multi-site trial of a manual-based intervention for patients with clinically-significant fear of cancer recurrence.

• Presentation unavailable

Dr Michelle Grogan, Senior Radiation Oncologist, RBWH

Dr Michelle Grogan MBBS, FRANZCR is a Senior Radiation Oncologist with special interests in breast cancer, genitourinary cancer, gastrointestinal tract cancer and gynaecological cancers.

After obtaining her fellowship in 1996, she undertook further training in breast, genitourinary and gynaecologic malignancies at the Breast Cancer Institute in Sydney and the Toronto Sunnybrook Hospital in Toronto, Canada.  On returning to Australia in 1999, Dr Grogan worked at the Prince of Wales Hospital, Sydney moving to Brisbane in 2007 to work at the Royal Brisbane and Women’s Hospital.

Dr Grogan has experience in treating with new technologies such as IMRT, VMAT, Tomotherapy and stereotactic radiotherapy and in the use of brachytherapy for management of genitourinary, gynaecologic and GI tract tumours.

Having published in peer review journals, Dr Grogan is committed to clinical research and has an active role in the education of trainees.

She practices at the Royal Brisbane & Women’s Hospital and privately at the Holy Spirit Northside.

• Presentation unavailable

• Presentation unavailable

Dr Jeffrey Goh

Dr Goh was appointed Staff Medical Oncologist at Royal Brisbane & Women’s Hospital (RBWH) in December 2008 after completing advanced training in Medical Oncology in Brisbane in late 2007 (FRACP). He obtained his Medical degree (MBBS) from Monash University in Victoria.

Dr Goh commenced part-time private practice at Greenslopes Private Hospital and ICON Chermside several years ago. This is combined with his current position as part-time, Senior Staff Medical Oncologist at RBWH. His previous experience in general Medical Oncology has more recently been fine-tuned and focused on gynaecological and genitourinary malignancies, in line with Dr Goh’s sub-specialty clinical research interests and increasing complexities in those areas. He also has secondary interests in cancer of unknown primary (CUP) and early phase (phase 1b) trials.

Dr Goh has also been actively involved in clinical trials including his role as principal investigator (PI) in a number of phase I, II and III gynaecological oncology and urological malignancy trials at RBWH and ICON Chermside. He is also involved with a small number of phase 1b and cancer of unknown primary (CUP) trials. He is also a co-investigator in numerous other multi-centre clinical trials in oncology. Dr Goh continues to maintain an active interest in clinical research. He is the chair of the Cervical Cancer Working Group of the Australia & New Zealand Gynaecological Oncology Group (ANZGOG). He is also an active member of ANZUP and ASCO.

Apart from being a clinician, Dr Jeffrey Goh has an ongoing commitment to the teaching and development of medical students in his position as senior lecturer, Faculty of Medicine, University of Queensland. Dr Goh is also fluent in three languages and two Chinese dialects.

• Presentation unavailable